NCT05711030 2024-02-20
TPVB
Ciusss de L'Est de l'Île de Montréal
Phase NA Unknown
Clinical Trials
12 trialsNCT05250791 2023-06-09
FLICOR
Imperial College London
Phase NA Unknown
NCT05797948 2023-04-04
GZL Sequential CD19/CD22 CAR-T in Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
The First Affiliated Hospital of Soochow University
Phase NA Unknown
NCT05720598 2023-02-09
POLA
Medical University of Lublin
Phase NA Unknown
NCT05560308 2022-10-03
Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown
NCT05369650 2022-05-11
To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients
West China Hospital
Phase NA Unknown
NCT05160740 2022-02-04
ICGMFITinPLC
Zhujiang Hospital
Phase NA Unknown
NCT04615806 2022-01-25
The Value of Lymph Node Dissection of Indocyanine Green-guided Near-infrared Fluorescent Imaging in Esophagectomy
Fujian Medical University Union Hospital
Phase NA Unknown
NCT05053386 2021-09-22
Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma
Zhejiang Cancer Hospital
Phase NA Unknown
NCT04920500 2021-06-09
Bioequivalence of Daunorubicin Cytarabine Liposomes in Naive AML Patients
CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Phase NA Unknown
NCT04489706 2020-07-28
Arsenic Trioxide in Recurrent and Metastatic Ovarian Cancer and Endometrial Cancer With P53 Mutation
Ruijin Hospital
Phase NA Unknown
NCT02208583 2014-08-05
Molecular Phenotype Changes and Personalized Treatment for CRPC
Tianjin Medical University Cancer Institute and Hospital
Phase NA Unknown